Evidence map›Paper›PMID 38319075›Full record

ArticleAntimicrobial agents and chemotherapy2024

Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating

Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Dose Optimization of Tilmicosin againstJournal of agricultural and food chemistry · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaonan ZhangDivision of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Yan WangYueyang Inspection and Testing Center, Yueyang, China.
Sanwang LiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Feifan XieDivision of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.ORCID 0000-0002-9038-2676
Hanxi YiDepartment of Pathology, School of Basic Medical Science, Central South University, Changsha, China.ORCID 0000-0001-6719-9788
Central South University · CN

Funding

MOST | National Natural Science Foundation of China (NSFC) 82073940MOST | National Natural Science Foundation of China (NSFC) 82373965Science and Technology Innovation Program of Hunan Province 2022RC1229
6 · The paper itself

Abstract

Bacterial infections, including those caused by

Indexed as

Pseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsCarbapenemsCritical IllnessHumansMeropenemMicrobial Sensitivity TestsAnti-Bacterial AgentsCarbapenemsMeropenemhollow fiber infection modelmeropenemPK/PDPseudomonas aeruginosasepsis

Identifiers

PMID38319075
PMCPMC10916391
OpenAlexW4391577241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.